Literature DB >> 12359501

Lessons from CRH knockout mice.

M Venihaki1, J Majzoub.   

Abstract

Corticotropin-releasing hormone (CRH), the major regulator of hypothalamic-pituitary-adrenal (HPA) axis, has a wide spectrum of actions within the central nervous system and the periphery. The development and use of Crh knockout mice (Crh-/-) has been an important tool for addressing the physiologic and pathologic roles of CRH. This review describes the generation and characterization ofCrh -deficient mice as well as the use of these mice to study the role of CRH in maternal and fetal HPA axes development and in the regulation of the adult HPA axis and behavior. The review concludes with information about recently discovered CRH-related peptides and their possible roles in some of the functions thought initially to be mediated by CRH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359501     DOI: 10.1054/npep.2002.0906

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  Lack of CRH Affects the Behavior but Does Not Affect the Formation of Short-Term Memory.

Authors:  Eva Varejkova; Eva Plananska; Jaromir Myslivecek
Journal:  Cell Mol Neurobiol       Date:  2017-08-07       Impact factor: 5.046

2.  Gene expression of phenylethanolamine N-methyltransferase in corticotropin-releasing hormone knockout mice during stress exposure.

Authors:  R Kvetnansky; L Kubovcakova; A Tillinger; L Micutkova; O Krizanova; E L Sabban
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

Review 3.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

4.  A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts.

Authors:  Olga Rassouli; George Liapakis; Iakovos Lazaridis; George Sakellaris; Kostas Gkountelias; Achille Gravanis; Andrew N Margioris; Katia P Karalis; Maria Venihaki
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.